IGKV2D-29 and Parkinson disease: The blockade of the A2A receptor might antagonize dopaminergic neurotransmission in aspects relevant to motor control in PD patients [140], and the effect of A2A antagonists has been supported by studies on rodent and primate PD models as well as preliminary clinical observations [141,142].